In conclusion, this study emphasizes the importance of antibody kinetics and inflammatory biomarkers in understanding COVID-19 progression, showing that IgG stability may protect against severe ARDS outcomes, while fluctuations in IgM levels correlate with immune dysregulation in severe ARDS cases. This evidence concerns the gene CD40LG and COVID-19.